[Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer. Its relation with molecular subtypes]. [electronic resource]
Producer: 20161213Description: 340-5 p. digitalISSN:- 2253-8070
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Axilla
- Biomarkers, Tumor -- analysis
- Breast Neoplasms -- chemistry
- Carcinoma -- chemistry
- Combined Modality Therapy
- Cyclophosphamide -- administration & dosage
- Docetaxel
- Epirubicin -- administration & dosage
- Female
- Filgrastim -- administration & dosage
- Fluorouracil -- administration & dosage
- Humans
- Lymph Node Excision
- Lymphatic Metastasis
- Mastectomy, Segmental
- Middle Aged
- Neoadjuvant Therapy
- Neoplasm Proteins -- analysis
- Neoplasm Staging
- Neoplasms, Hormone-Dependent -- chemistry
- Paclitaxel -- administration & dosage
- Prospective Studies
- Receptor, ErbB-2 -- analysis
- Sentinel Lymph Node Biopsy -- methods
- Taxoids -- administration & dosage
- Trastuzumab -- administration & dosage
- Triple Negative Breast Neoplasms -- chemistry
No physical items for this record
Publication Type: Journal Article; Validation Study
There are no comments on this title.
Log in to your account to post a comment.